EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $621,000 | -61.6% | 72,925 | -60.1% | 0.00% | -66.7% |
Q1 2021 | $1,616,000 | -47.8% | 182,632 | -27.5% | 0.01% | -62.5% |
Q4 2020 | $3,097,000 | +94.3% | 251,961 | +120.9% | 0.02% | +14.3% |
Q1 2019 | $1,594,000 | +211.9% | 114,038 | +126.5% | 0.02% | +133.3% |
Q4 2018 | $511,000 | – | 50,342 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
RA Capital Management | 354,200 | $4,056,000 | 0.50% |
DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |